approval
saveMYCOPHENOLATE MOFETIL — FDA approval
community read0 votes
Sponsor: AUROBINDO PHARMA LTD. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalMYCOPHENOLATE MOFETIL — FDA approvalApr 10, 2026 · 177d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalMar 18, 2026 · 200d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalFeb 23, 2026 · 223d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalJan 14, 2026 · 263d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalJan 14, 2026 · 263d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalSep 26, 2024 · 738d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalAug 13, 2024 · 782d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalAug 13, 2024 · 782d ago
same company · ±60 days · 6
- approvalMYCOPHENOLATE MOFETIL: MYCOPHENOLATE MOFETIL — FDA approvalAug 13, 2024
- approvalmycophenolate sodium DR: MYCOPHENOLATE SODIUM — FDA approvalAug 13, 2024
- approvalVIGABATRIN: VIGABATRIN — FDA approvalSep 12, 2024
- approvalVIGABATRIN: VIGABATRIN — FDA approvalSep 12, 2024
- approvalERTUGLIFLOZIN: ERTUGLIFLOZIN — FDA approvalJul 11, 2024
- approvalMYCOPHENOLATE MOFETIL: MYCOPHENOLATE MOFETIL — FDA approvalSep 26, 2024
comments(0)
5-min edit window · permanent after that